AIGH Capital Management »

Byrna Technologies shares owned by AIGH Capital Management

Quarter-by-quarter ownership of Byrna Technologies (BYRN) shares owned by AIGH Capital Management from 13F filings

Historical chart of AIGH Capital Management investment in Byrna Technologies

Tip: Access up to 7 years of quarterly data

All positions including Byrna Technologies held by AIGH Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Byrna Technologies by AIGH Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.6M 395k 16.79

More positions owned by AIGH Capital Management

Sandisk Corp (SNDK)
Zoom Communications Call Call Option
Castle Biosciences (CSTL)
Personalis Ord (PSNL)
Nlight (LASR)
Day One Biopharmaceuticals I (DAWN)
Vanda Pharmaceuticals (VNDA)
Bk Technologies Corporation Com New (BKTI)
Domo Com Cl B (DOMO)
Esperion Therapeutics (ESPR)
Kyverna Therapeutics (KYTX)
Fennec Pharmaceuticals (FENC)
Lightpath Technologies Com Cl A (LPTH)
Abeona Therapeutics Com New (ABEO)
Zevra Therapeutics Call Call Option

View all positions for AIGH Capital Management

Top funds holding Byrna Technologies

FMR
Capital Research Global Investors
BlackRock
Vanguard Group
State Street Corporation
Millennium Management
UBS Group
Driehaus Capital Management
Geode Capital Management
AIGH Capital Management
Citadel Advisors
Arrowpoint Asset Management
Susquehanna International
Sontag Advisory
Dimensional Fund Advisors

View all funds holding Byrna Technologies